 |
Hot Pursuit
15-Mar-25
|
 |
|
|
|
|
|
Alkem Lab’s Bioequivalence Center clears USFDA inspection without observations
|
Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) conducted a Bioresearch Monitoring (BIMO) inspection at its Bioequivalence Center in Taloja, Maharashtra, from 10 March to 13 March 2025.
|
|
|
The inspection concluded that no Form 483 had been issued.
Alkem Laboratories is engaged in the pharmaceutical business with global operations. The company is engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products.
The company’s consolidated net profit declined 1.8% to Rs 625.82 crore in Q3 FY25 as compared with Rs 637.37 crore in Q3 FY24. Net sales rose 1.5% YoY to Rs 3,374.28 crore in Q3 FY25.
Shares of Alkem Laboratories shed 0.97% to end at Rs 4,704.10 on Thursday, 13 March 2025.
|
|
Previous News |
Alkem Laboratories announces appointment of senior management personnel
(
Corporate News
-
10-Mar-25
14:10
)
|
|
Alkem Laboratories Ltd slips for fifth straight session
(
Hot Pursuit
-
11-Jan-24
13:35
)
|
|
Alkem Laboratories Ltd leads losers in 'A' group
(
Hot Pursuit
-
26-Feb-24
15:00
)
|
|
Alkem Laboratories Ltd soars 2.24%
(
Hot Pursuit
-
04-Oct-24
13:05
)
|
|
Alkem Laboratories Ltd up for fifth session
(
Hot Pursuit
-
09-Jul-24
13:01
)
|
|
Alkem Laboratories fixes record date for interim dividend
(
Market Beat
-
Reports
24-Jan-22
18:24
)
|
|
Alkem Laboratories Ltd spurts 1.62%, rises for third straight session
(
Hot Pursuit
-
22-Dec-22
13:05
)
|
|
Board of Alkem Laboratories appoints director
(
Corporate News
-
14-Sep-22
13:54
)
|
|
Alkem Laboratories Ltd spurts 1.76%, gains for fifth straight session
(
Hot Pursuit
-
26-Jul-23
13:00
)
|
|
Alkem Laboratories consolidated net profit rises 30.84% in the December 2023 quarter
(
Results
-
Announcements
09-Feb-24
14:30
)
|
|
Alkem Laboratories Ltd soars 1.6%, rises for third straight session
(
Hot Pursuit
-
17-May-24
13:05
)
|
|
|
 |
Other Stories |
 |
|
|
|
|
|
|
|